Breaking News
Get 40% Off 0
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did. Read how

TipRanks TipRanks

TipRanks's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by TipRanks, including current material.
Analysts Positive On BioLine Rx By Sarah Roden - May 05, 2015

By Sarah RodenOn May 4, Bioline Rx (NASDAQ:BLRX) announced the expansion stage of the Phase 2 clinical trial for BL-8040, a drug for acute myeloid leukemia, or AML. Top-line results will be announced...

Continue with Google
or
Sign up with Email